Please login to the form below

Matt Hancock

This page shows the latest Matt Hancock news and features for those working in and with pharma, biotech and healthcare.

As May delays, industry warns again of ‘no-deal’ Brexit

The letter from health minister Matt Hancock – which suggested there could be disruption of up to six months at Dover – was however met with frustration by the ABPI and BioIndustry Association

Latest news

Industry frustrated by late warning on 'no deal' Brexit disruption

Health secretary Matt Hancock has written to pharma companies today, warning that the government’s previous advice that they build up six weeks’ worth of medicines stockpiles won’t be enough, ... Read Matt Hancock’s letter outlining preparations
Genomics England reaches 100,000th genome sequencing milestone

The UK hit a major milestone yesterday after Health Secretary Matt Hancock announced that Genomics England sequenced its 100, 000. ... The end game was to make the UK a leader in genomic medicine within five years, and according to health secretary Matt
New ‘voluntary’ UK pricing deal caps growth, but promises faster uptake

Health secretary Matt Hancock: "tough but constructive negotiations". Health secretary Matt Hancock says the proposed agreement has come out of “tough but constructive negotiations”. ... Announcing the deal, Matt Hancock said: “This new deal will
Abbott’s wearable glucose monitor to be available across England

The announcement comes just one month after Health Secretary Matt Hancock unveiled a nation-wide strategy to put technology at the forefront of the NHS, but has since been challenged by
Decision time for Brexit

Industry bodies, including the ABPI, BIA and EMIG wrote a joint letter to the health secretary Matt Hancock two weeks ago, requesting an 'urgent roundtable' on no deal medicines supply chain

More from news
Approximately 4 fully matching, plus 16 partially matching documents found.

Latest Intelligence

Happy 70th birthday NHS: the next 70 need to be very different

NHS Confederation leaders have written to new health secretary Matt Hancock (pictured above) urging him to ‘grasp the social care challenge’.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Associate Medical Director: Excellent PTO, bonus and 401k package

CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...: EXCELLENT DAY RATES AVAILABLE

Senior Account Executive with progression to Account Manager, Me...: Excellent package

Medical (Scientific) Director: £120, 000 benefits

SAE – Healthcare PR – Award-Winning Consultancy: Salary TBC

Senior Editorial Assistant – Greater Manchester: DOE

Systematic Reviewer - Oxford: Negotiable

Account Manager / Senior Account Manager: 35, 000-40, 000

Medical Writer: Salary TBC

Business Director: Competitive Salary Offered

Senior Developer with management potential, Healthcare Brand Com...: circa £50K

Principal Health Economist - North-West: Negotiable

Medical Writer: Bonus Scheme, PTO &Private Healthcare

Account Manager / Account Director: Competative

Account Manager: Negotiable

Account Director – Healthcare Marketing – Berks: Salary TBC

Experienced Medical Writers: Competitive Salary and Benefits

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Editorial Manager - MedComms: DOE

Healthcare Communications Account Directors x 2: Salary TBC

Associate Director: £75, 000-90, 000

Senior Account Manager: Competitive Salary Offered

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Account Director: Competitive Salary Offered

Business Development Director – Health Education: excellent commission

Subscribe to our email news alerts

PMHub

Add my company

huumun formerly PharmiWeb Solutions

huumun, is a digital transformation business. For us, digital transformation means using digital technologies, not just to turn an existing...

Latest intelligence

Is China ready for a pharmaceutical gold rush?: Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance: Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis: Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...